Harmony Biosciences Holdings (HRMY) Change in Acquisitions & Divestments (2022 - 2026)

Harmony Biosciences Holdings (HRMY) has 5 years of Change in Acquisitions & Divestments data on file, last reported at $27.3 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Acquisitions & Divestments rose 26.49% year-over-year to $27.3 million; the trailing twelve-month figure through Mar 2026 stood at $86.8 million (down 14.26% YoY), and the FY2025 full-year result was $81.1 million, down 17.73% from the prior year.
• Change in Acquisitions & Divestments improved to $27.3 million in Q1 2026, from $20.6 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $46.0 million in Q1 2023 to a low of $8.2 million in Q4 2022.
• A 5-year average of $23.8 million and a median of $22.1 million in 2023 frame the typical range for Change in Acquisitions & Divestments.
• Across the five-year window, Change in Acquisitions & Divestments soared 175.98% in 2023 and plunged 58.85% in 2024, its largest moves.
• Tracing HRMY's Change in Acquisitions & Divestments over 5 years: stood at $8.2 million in 2022, then surged by 175.98% to $22.6 million in 2023, then surged by 32.66% to $30.0 million in 2024, then tumbled by 31.49% to $20.6 million in 2025, then jumped by 33.01% to $27.3 million in 2026.
• Business Quant data shows HRMY's Change in Acquisitions & Divestments at $27.3 million in Q1 2026, $20.6 million in Q4 2025, and $19.6 million in Q3 2025.